氯氮平可降低慢性精神分裂症患者的吸烟量。 - Suppr

Suppr

超能文献

Clozapine decreases smoking in patients with chronic schizophrenia.

作者信息

McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J

机构信息

Department of Psychiatry, Duke University Medical Center, NC, USA.

出版信息

Biol Psychiatry. 1995 Apr 15;37(8):550-2. doi: 10.1016/0006-3223(94)00365-A.

DOI:10.1016/0006-3223(94)00365-A

PMID:7619979

Abstract

摘要

相似文献

Clozapine decreases smoking in patients with chronic schizophrenia.氯氮平可降低慢性精神分裂症患者的吸烟量。

Biol Psychiatry. 1995 Apr 15;37(8):550-2. doi: 10.1016/0006-3223(94)00365-A.

Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.

J Clin Psychiatry. 1991 Aug;52(8):346-8.

[Value of neuroleptic therapy in the self assessment of schizophrenic patients].

Psychiatr Neurol Med Psychol (Leipz). 1987 Aug;39(8):487-91.

Stability of neurological signs with clozapine treatment.

Biol Psychiatry. 1994 Aug 1;36(3):198-200. doi: 10.1016/0006-3223(94)91225-4.

Coadministration of fluvoxamine increases serum concentrations of haloperidol.

J Clin Psychopharmacol. 1994 Oct;14(5):340-3.

Does clozapine affect smoking rates?氯氮平会影响吸烟率吗？

Aust N Z J Psychiatry. 1998 Dec;32(6):890-1.

An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia.氯氮平治疗11例儿童期起病精神分裂症青少年的开放性试验。

J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):658-63. doi: 10.1097/00004583-199406000-00006.

Clinical efficacy of clozapine in the treatment of schizophrenia.

Pharmacopsychiatry. 1991 Mar;24(2):44-5.

Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.使用氯氮平或氟哌啶醇治疗的精神分裂症患者的强迫症状和障碍。

Compr Psychiatry. 2009 Sep-Oct;50(5):437-42. doi: 10.1016/j.comppsych.2008.11.005. Epub 2009 Jan 15.

Plasma clozapine levels and clinical benefit.

J Clin Psychiatry. 1995 Nov;56(11):535-6.

引用本文的文献

Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.经典和非经典抗精神病药物与现有和下一代分子的多巴胺相关机制：针对治疗反应和治疗抵抗性精神分裂症的转化研究亮点的系统综述。

Int J Mol Sci. 2023 Mar 21;24(6):5945. doi: 10.3390/ijms24065945.

The relationship between nicotine and psychosis.尼古丁与精神病之间的关系。

Ther Adv Psychopharmacol. 2019 Jul 1;9:2045125319859969. doi: 10.1177/2045125319859969. eCollection 2019.

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.从美沙酮维持治疗双相障碍海洛因使用障碍患者中我们学到了什么。

Int J Environ Res Public Health. 2019 Feb 3;16(3):447. doi: 10.3390/ijerph16030447.

Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.吸烟与精神分裂症中的抗精神病药物、身体侵犯和酒精使用障碍有关：来自 FACE-SZ 全国队列的研究结果。

Eur Arch Psychiatry Clin Neurosci. 2019 Jun;269(4):449-457. doi: 10.1007/s00406-018-0873-7. Epub 2018 Feb 2.

Clozapine dose for schizophrenia.用于治疗精神分裂症的氯氮平剂量。

Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD009555. doi: 10.1002/14651858.CD009555.pub2.

Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.使用伐尼克兰和认知行为戒烟疗法治疗的精神分裂症或双相情感障碍门诊吸烟者戒烟的预测因素。

Addict Behav. 2017 Aug;71:89-95. doi: 10.1016/j.addbeh.2017.02.028. Epub 2017 Feb 24.

Nicotinic modulation of salience network connectivity and centrality in schizophrenia.精神分裂症中烟碱对突显网络连通性和中心性的调节作用

J Psychiatr Res. 2017 Jun;89:85-96. doi: 10.1016/j.jpsychires.2017.01.018. Epub 2017 Feb 3.

Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.精神分裂症患者的抗精神病药物治疗与烟草渴望

J Dual Diagn. 2017 Jan-Mar;13(1):36-42. doi: 10.1080/15504263.2017.1288946.

Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.在雌性大鼠中，通过慢性尼古丁输注并阻断H1组胺来减少尼古丁自我给药。

Psychopharmacology (Berl). 2016 Aug;233(15-16):3009-15. doi: 10.1007/s00213-016-4347-1. Epub 2016 Jun 18.

The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.α7 烟碱型乙酰胆碱受体（α7 nAChR）激动剂治疗精神分裂症相关认知障碍的治疗潜力。

CNS Drugs. 2015 Jul;29(7):529-42. doi: 10.1007/s40263-015-0260-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验